FDA’s Manufacturing Registration Rule’s Impact on Advanced Therapies: Part 2

Jul 29, 2026

In part 2 of this 2-part interview, Jason Bock, founder and CEO of CTMC provides input on how the FDA’s proposed manufacturing registration rule may impact personalized therapies.

Listen to Part 2 here: PharmTech Part 2

Recent News